Not me. I don't see what's so great about ti if it is mostly a control for hunger. Most overweight people want the benefits of the GLPs.
View attachment 24000
Similar to my other post. This drug seems more like an add on for people with severe hunger control issues or who don't respond well to the appetite suppression the GLP-1, GIP, Glucagon drugs provide.
I am sure influencers will hype this, but why go after 1 health issue when you can go after three with a single drug. Lilly is just dragging out the inevitable. Mixing the eloralintide with the reta for the Quadrotutide. They'll just keep a steady stream going with breaks in between to keep the money printing.